Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study
AIDS and Behavior · 2025
DOI: 10.1007/s10461-024-04594-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Susan Tross und 20 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Irving Medical Center, New York, NY, USA. st130@cumc.columbia.edu. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Homosexuality, Male, Patient Acceptance of Health Care. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
In Southern U.S. states with high HIV incidence and low HIV Pre-Exposure Prophylaxis (PrEP) uptake, enhanced efforts to increase interest in and willingness to use PrEP are needed. This implementation survey examined the associations of sociodemographic background, substance use, and sexual risk behaviors with willingness to use daily oral and long-acting injectable (LAI) PrEP among substance using men who have sex with men (SU-MSM). Participants were 225 SU-MSM recruited from sexually transmitted infection (STI) clinics, syringe services programs (SSPs), and substance use treatment programs (SUTPs) in eight Southern U.S. cities. Rates of willingness were high for both daily oral PrEP (78%) and LAI PrEP (66%). In multivariable analyses, distinct factors were associated with willingness towards each. For daily oral PrEP, greater willingness was associated with condomless anal sex, less frequent non-injection opioid use, prior PrEP awareness, and past use of PrEP. For LAI PrEP, greater willingness was associated with Black race, identifying as gay, being single, and higher injection drug use frequency. Lower willingness to use LAI PrEP was associated with higher non-injection opioid use frequency. Findings about willingness to use LAI PrEP, as a relatively newer modality, and greater willingness among Black SU-MSM as a disproportionately HIV-impacted population, are especially important. These findings argue for the necessity to enhance PrEP promotion efforts that distinguish between oral and LAI PrEP and that are specifically tailored to major SU-MSM subgroups in the Southern U.S.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Columbia University Irving Medical Center, New York, NY, USA. st130@cumc.columbia.edu.
- University of Washington Addictions, Drug & Alcohol Institute, Department of Psychiatry and Behavioral Sciences, Seattle, WA, USA.
- Columbia University Irving Medical Center, New York, NY, USA.
- Present address: Department of Psychology, University of Minnesota, Minneapolis, MN, USA.
- Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
- Department of Leadership, Policy, and Lifelong Learning, University of South Florida, Tampa, FL, USA.
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIMH NIH HHS
- NIDA NIH HHS
- NIH
- NIDA
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Tross, S., Laschober, T. C., Paschen-Wolff, M., Ertl, M., Nelson, C. M., Wright, L., Lancaster, C., Feaster, D. J., Monger, M., Toal, P., Fegley, J. P., Meche, D., Hankey, C., Woodhouse, C., Spector, A., Dresser, L., Moran, L., Jelstrom, E., Haynes, L., …, & Hatch, M. A. (2025). Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04594-7
Vancouver
Tross S, Laschober TC, Paschen-Wolff M, Ertl M, Nelson CM, Wright L, et al. Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study. AIDS and Behavior. 2025. doi:10.1007/s10461-024-04594-7
BibTeX
@article{Tross2025,
author = {Tross, Susan and Laschober, Tanja C and Paschen-Wolff, Margaret and Ertl, Melissa and Nelson, C Mindy and Wright, Lynette and Lancaster, Chloe and Feaster, Daniel J and Monger, Mauda and Toal, Phil and Fegley, Joshua P and Meche, David and Hankey, Colby and Woodhouse, Christina and Spector, Anya and Dresser, Lauren and Moran, Landhing and Jelstrom, Eve and Haynes, Louise and Shoptaw, Steven and Hatch, Mary A},
title = {Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study},
journal = {AIDS and Behavior},
year = {2025},
doi = {10.1007/s10461-024-04594-7}
}
EUVIMED